Clinical Research & CRO
16 posts
The Obesity and Metabolic Disease Trial Boom: What Site Networks Should Know
How the GLP-1 era has transformed sponsor demand for metabolic disease trial sites, and what site networks need to compete for allocation.
Diversity in Clinical Trials: Regulatory Trends and Practical Site Strategies
How clinical trial diversity requirements are reshaping site selection, and what it actually takes to build trusted, effective diverse recruitment.
ICH E6(R3): Inside the Biggest GCP Overhaul in 25 Years, and What It Means for Clinical Trial Sites
Seven Health's guide to ICH E6(R3), the most significant Good Clinical Practice overhaul in a generation, and what it means for site quality systems.
Asia-Pacific's Rise as a Global Clinical Trial Hub: What It Means for U.S. Site Networks
How Asia-Pacific's rapidly growing clinical trials market is reshaping the competitive bar for U.S. clinical trial site networks in 2026.
Real-World Evidence: How RWE Is Reshaping Clinical Trial Design
How real-world evidence has moved from a post-approval afterthought to a central input in clinical trial design and regulatory strategy.
Oncology and Rare Disease Trials: Why Rising Complexity Is Reshaping Site Selection
A Seven Health look at why oncology and rare disease complexity is reshaping what sponsors look for in a clinical trial site partner.